← All verdicts
Verdict

Data Unavailable

Every analyzed stock in Data Unavailable — 2,921 companies. Each card shows price, our model's intrinsic value (IV), and how far price sits above or below it. Click any card for the full analysis. This is a research-triage view, not a buy/sell signal.

Educational use only — not investment advice. "Undervalued / fairly valued / overvalued" and every risk score reflect our models vs. price, which can be wrong or based on stale or incomplete data. Always review the company's own financials and SEC filings, and consult a licensed advisor, before acting.
"Data Unavailable" by: Model value (price vs DCF) Owner-earnings return (equity bond)

This lens: price against our probability-weighted DCF value (P/IV). Its own forward record began accruing on 2026-09-10 (daily snapshots); until a year of it exists, the panel below tests the nearest cousin we can measure point-in-time — cheap on book value — and says so.

Market state today: Calm — the S&P 500 closed 3.1% below its 1-year high (as of 2026-09-16). Our rule, the same one used to split every backtest on this site: sell-off = 10% or more below the 1-year high, borderline from 5%, calm otherwise. A further 7.2% fall from here would put us in a sell-off. Since 2006 the market has been in a sell-off 16.6% of the time, across 13 episodes (red bands).
2007200920112013201520172019202120232025
S&P 500 (SPY, adjusted) distance from its trailing 1-year high, weekly. Amber band: borderline (−5% to −10%). Red band: sell-off (below −10%). The dot is today. History to 2026-08-19 from the research database; today from the live feed.
Backtest · point in time · 8,702 entries in the study

Does this screen work? The record for exactly these filters

Screen tested: Proxy: price-to-book ≤ 1.2 (undervalued band has no point-in-time history yet) · bought the day of the annual report, held 12 months
Probable Buy every company that met this screen on the day it filed its annual report, hold 12 months: on average it beat the S&P 500 by +12.6 pts (1,427 entries, 311 companies, very unlikely to be luck). 50% of entries beat the S&P; 25% beat it by 30 points or more; 30% trailed it by 20 points or more. Owning everything instead averaged +1.7 pts, so the screen's edge is +10.9 pts.
+12.6 ptsvs S&P, average
50%beat the S&P
25%up 30+ pts vs S&P
30%down 20+ pts vs S&P
+14.0 ptsvs small caps, 12 mo
−15.1 pts 2019worst year to buy ?
6.1luck check ?
Does the holding period matter?3 mo: +2.3 pts 49% beat6 mo: +4.6 pts 49% beat12 mo: +12.6 pts 50% beat24 mo: +21.8 pts 46% beat3 yr, per yr: +1.3 pts 40% beat
Market state at entryCompany-yearsvs S&P 12 movs small caps
Calm ◀ today1,245+7.9 pts t 4.6+10.1 pts
Sell-off (S&P ≥10% off high)182+44.5 pts t 4.0+40.7 pts
Sector (SEC group)nvs S&P 12 mo3 yrs / yr
Industrials & manufacturing466+13.0 pts t 4.0−2.2 pts
Energy126+7.4 pts t 1.2−7.8 pts
Other115+8.4 pts t 1.8+3.8 pts
Tech hardware & semis113+10.9 pts t 1.6+2.3 pts
Services96+11.9 pts t 2.7+12.2 pts
Retail & consumer87+17.2 pts t 2.1+10.2 pts
Finance & real estate72−1.7 pts t -0.5−2.4 pts
Utilities65+5.6 pts t 0.6−1.2 pts
Construction53+13.2 pts t 1.7−2.4 pts
Biotech & pharma44+47.1 pts t 1.6+10.0 pts
Telecom & media43+14.0 pts t 0.7−6.3 pts
Software & IT services35+39.9 pts t 1.8+1.2 pts

Holds up out of sample? Before 2018: +10.7 pts (n 629, t 6.0). From 2018: +14.0 pts (n 798, t 4.1). Same sign in both halves.

Year2010201120122013201420152016201720182019202020212022202320242025
vs S&P+13 pts+5 pts+14 pts+18 pts−4 pts−4 pts+22 pts+12 pts−3 pts−15 pts+87 pts+8 pts+17 pts−9 pts−7 pts+15 pts
n254310610178841118178991297276108121115

Read the research behind this screen: Price-to-book still sorts, across all sizes → · Test your own combination in the Screen Lab →

Our model values are recomputed daily but were never stored historically, so this band cannot be backtested honestly yet. Daily snapshots began 2026-09-10; a true record accrues from there. Until then the nearest tested cousin is shown — cheap on book value — and labelled as a proxy. Point-in-time: each entry is one company bought at the first close after its 10-K filing date, using only filings available that day, held 12 months; result = total return minus SPY over the same months (vs IWM for 12 months; 3-yr annualised). Survivorship-tilted universe; no costs; read spreads, not levels. Educational, hypothetical, before costs.

Sort by: A–Z Riskiest Most overvalued Most shorted Buyers' strike Largest
PDFS
PDF SOLUTIONS INC
Valuation N/A
Technology Risk 42 · Elevated
Price$47.77
Model IV—
P/IV—
Market implies +35.4%/yr vs model +18.5% · above model
PDI
PIMCO Dynamic Income Fund
Valuation N/A
Unknown
Price$14.25
Model IV—
P/IV—
Limited data — see page
PDO
PIMCO Dynamic Income Opportunities Fund
Valuation N/A
Unknown
Price$12.36
Model IV—
P/IV—
Limited data — see page
PDPA
Pearl Diver Credit Co Inc.
Valuation N/A
Unknown
Price$25.17
Model IV—
P/IV—
Limited data — see page
PDS
PRECISION DRILLING Corp
Valuation N/A
Energy Risk 51 · Elevated
Price$89.77
Model IV—
P/IV—
Limited data — see page
PDSB
PDS Biotechnology Corp
Valuation N/A
Healthcare Risk 42 · Elevated
Price$0.29
Model IV—
P/IV—
Limited data — see page
PDT
JOHN HANCOCK PREMIUM DIVIDEND FUND
Valuation N/A
Unknown
Price$12.01
Model IV—
P/IV—
Limited data — see page
PDX
PIMCO Dynamic Income Strategy Fund
Valuation N/A
Unknown
Price$21.63
Model IV—
P/IV—
Limited data — see page
PDYN
Palladyne AI Corp.
Valuation N/A
Technology Risk 40 · Elevated
Price$5.77
Model IV—
P/IV—
Market implies +97.1%/yr vs model +2.0% · above model
PEB
Pebblebrook Hotel Trust
Valuation N/A
Financial Services Risk 51 · Elevated
Price$17.84
Model IV—
P/IV—
Limited data — see page
PENG
Penguin Solutions, Inc.
Valuation N/A
Technology Risk 45 · Elevated
Price$46.59
Model IV—
P/IV—
Market implies +29.3%/yr vs model +8.3% · above model
PEO
ADAMS NATURAL RESOURCES FUND, INC.
Valuation N/A
Unknown
Price$29.33
Model IV—
P/IV—
Limited data — see page
PEPG
PepGen Inc.
Valuation N/A
Healthcare Risk 29 · Moderate
Price$2.98
Model IV—
P/IV—
Limited data — see page
PERF
Perfect Corp.
Valuation N/A
Technology
Price$1.93
Model IV—
P/IV—
Limited data — see page
PETZ
TDH Holdings, Inc.
Valuation N/A
Real Estate Risk 29 · Moderate
Price$1.33
Model IV—
P/IV—
Market implies +27.0%/yr vs model +3.7% · above model
PFAI
Pinnacle Food Group Ltd
Valuation N/A
Basic Materials
Price$3.01
Model IV—
P/IV—
Limited data — see page
PFBC
Preferred Bank
Valuation N/A
Unknown
Price$105.81
Model IV—
P/IV—
Limited data — see page
PFD
FLAHERTY & CRUMRINE PREFERRED & INCOME FUND INC
Valuation N/A
Unknown
Price$10.94
Model IV—
P/IV—
Limited data — see page
PFL
PIMCO INCOME STRATEGY FUND
Valuation N/A
Unknown
Price$7.33
Model IV—
P/IV—
Limited data — see page
PFLT
PennantPark Floating Rate Capital Ltd.
Valuation N/A
Unknown Risk 51 · Elevated
Price$7.12
Model IV—
P/IV—
Limited data — see page
PFN
PIMCO Income Strategy Fund II
Valuation N/A
Unknown
Price$6.64
Model IV—
P/IV—
Limited data — see page
PFO
Flaherty & Crumrine PREFERRED & INCOME OPPORTUNITY FUND INC
Valuation N/A
Unknown
Price$8.96
Model IV—
P/IV—
Limited data — see page
PFSA
Profusa, Inc.
Valuation N/A
Healthcare Risk 28 · Moderate
Price$2.43
Model IV—
P/IV—
Market implies +33.5%/yr vs model +15.0% · above model
PFSI
PennyMac Financial Services, Inc.
Valuation N/A
Financial Services Risk 40 · Elevated
Price$70.36
Model IV—
P/IV—
Market implies +58.9%/yr vs model +28.7% · above model
PFX
PhenixFIN Corp
Valuation N/A
Unknown Risk 27 · Moderate
Price$45.99
Model IV—
P/IV—
Limited data — see page
PFXNZ
PhenixFIN Corp
Valuation N/A
Unknown Risk 37 · Moderate
Price$23.97
Model IV—
P/IV—
Limited data — see page
PGAC
PANTAGES CAPITAL ACQUISITION Corp
Valuation N/A
Financial Services
Price$10.71
Model IV—
P/IV—
Limited data — see page
PGACR
PANTAGES CAPITAL ACQUISITION Corp
Valuation N/A
Financial Services
Price$0.15
Model IV—
P/IV—
Limited data — see page
PGACU
PANTAGES CAPITAL ACQUISITION Corp
Valuation N/A
Financial Services
Price$10.85
Model IV—
P/IV—
Limited data — see page
PGEN
PRECIGEN, INC.
Valuation N/A
Healthcare Risk 53 · Elevated
Price$6.85
Model IV—
P/IV—
Market implies +109.0%/yr vs model +2.0% · above model
PGP
PIMCO Global StocksPLUS & Income Fund
Valuation N/A
Unknown
Price$8.51
Model IV—
P/IV—
Limited data — see page
PGZ
Principal Real Estate Income Fund
Valuation N/A
Unknown
Price$9.52
Model IV—
P/IV—
Limited data — see page
PHG
KONINKLIJKE PHILIPS NV
Valuation N/A
Healthcare Risk 34 · Moderate
Price$24.59
Model IV—
P/IV—
Limited data — see page
PHGE
BiomX Inc.
Valuation N/A
Healthcare Risk 39 · Moderate
Price$0.97
Model IV—
P/IV—
Limited data — see page
PHI
PLDT Inc.
Valuation N/A
Communication Services Risk 58 · Elevated
Price$18.38
Model IV—
P/IV—
Limited data — see page
PHIO
Phio Pharmaceuticals Corp.
Valuation N/A
Healthcare Risk 42 · Elevated
Price$1.03
Model IV—
P/IV—
Limited data — see page
PHK
PIMCO HIGH INCOME FUND
Valuation N/A
Unknown
Price$4.36
Model IV—
P/IV—
Limited data — see page
PHUN
Phunware, Inc.
Valuation N/A
Technology Risk 39 · Moderate
Price$2.03
Model IV—
P/IV—
Market implies +76.8%/yr vs model +2.0% · above model
PHVS
Pharvaris N.V.
Valuation N/A
Healthcare Risk 45 · Elevated
Price$38.86
Model IV—
P/IV—
Limited data — see page
PHYS
Sprott Physical Gold Trust
Valuation N/A
Financial Services Risk 40 · Elevated
Price$32.43
Model IV—
P/IV—
Limited data — see page
PI
IMPINJ INC
Valuation N/A
Technology Risk 59 · Elevated
Price$176.82
Model IV—
P/IV—
Market implies +34.5%/yr vs model +17.4% · above model
PICS
PicS N.V.
Valuation N/A
Financial Services
Price$10.30
Model IV—
P/IV—
Limited data — see page
PIII
P3 Health Partners Inc.
Valuation N/A
Healthcare Risk 50 · Elevated
Price$8.43
Model IV—
P/IV—
Market implies -50.0%/yr vs model +26.0% · below model
PIIIW
P3 Health Partners Inc.
Valuation N/A
Healthcare Risk 36 · Moderate
Price$0.01
Model IV—
P/IV—
Limited data — see page
PIM
PUTNAM MASTER INTERMEDIATE INCOME TRUST
Valuation N/A
Unknown
Price$3.08
Model IV—
P/IV—
Limited data — see page
PJT
PJT Partners Inc.
Valuation N/A
Financial Services
Price$163.21
Model IV—
P/IV—
Limited data — see page
PKE
PARK AEROSPACE CORP
Valuation N/A
Industrials Risk 60 · High
Price$31.76
Model IV—
P/IV—
Market implies +29.8%/yr vs model +7.6% · above model
PKX
POSCO HOLDINGS INC.
Valuation N/A
Basic Materials
Price$62.94
Model IV—
P/IV—
Limited data — see page
PL
Planet Labs PBC
Valuation N/A
Technology Risk 41 · Elevated
Price$16.20
Model IV—
P/IV—
Market implies +87.6%/yr vs model +20.2% · above model
PLAG
Planet Green Holdings Corp.
Valuation N/A
Consumer Defensive Risk 39 · Moderate
Price$0.72
Model IV—
P/IV—
Market implies +27.7%/yr vs model +2.0% · above model
PLBL
Polibeli Group Ltd
Valuation N/A
Industrials Risk 37 · Moderate
Price$5.53
Model IV—
P/IV—
Market implies +49.2%/yr vs model +5.1% · above model
PLG
PLATINUM GROUP METALS LTD
Valuation N/A
Basic Materials Risk 29 · Moderate
Price$1.46
Model IV—
P/IV—
Limited data — see page
PLMK
Plum Acquisition Corp, IV
Valuation N/A
Financial Services
Price$10.67
Model IV—
P/IV—
Limited data — see page
PLMKU
Plum Acquisition Corp, IV
Valuation N/A
Financial Services
Price$10.74
Model IV—
P/IV—
Limited data — see page
PLMKW
Plum Acquisition Corp, IV
Valuation N/A
Financial Services
Price$0.35
Model IV—
P/IV—
Limited data — see page
PLPC
PREFORMED LINE PRODUCTS CO
Valuation N/A
Industrials Risk 55 · Elevated
Price$403.10
Model IV—
P/IV—
Market implies +31.6%/yr vs model +6.5% · above model
PLRX
PLIANT THERAPEUTICS, INC.
Valuation N/A
Healthcare Risk 31 · Moderate
Price$1.12
Model IV—
P/IV—
Market implies +47.7%/yr vs model +15.0% · above model
PLRZ
Polyrizon Ltd.
Valuation N/A
Healthcare Risk 42 · Elevated
Price$11.03
Model IV—
P/IV—
Limited data — see page
PLSE
PULSE BIOSCIENCES, INC.
Valuation N/A
Healthcare Risk 37 · Moderate
Price$53.11
Model IV—
P/IV—
Market implies +150.0%/yr vs model +2.0% · above model
PLSM
Pulsenmore Ltd.
Valuation N/A
Healthcare Risk 35 · Moderate
Price$2.41
Model IV—
P/IV—
Limited data — see page